EASL 2020

European Association for the Study of the Liver Annual Congress 2020

SECURE HOUSING

Book Hotel Near Venue II FREE CANCELLATION ll

ABOUT EASL 2020



Welcome to EASL The International Liver Congress



The European Association for the Study of the Liver started as a small group of 70 hepatologists from 15 European countries who came together to share best medical practice in April 1966. Over half a century later EASL has evolved into a major European Association with international influence dedicated to the liver and liver disease.

EASL congress has over 7,000 members from all over the world and provides an annual platform, The International Liver Congress, for 14,000 liver experts to meet and discuss latest scientific research. EASL congress has given rise to many international clinical trials and research collaborations to the benefit of patients all over the world.



Meeting Location



Congress Venue: The World-Class ExCeL Centre in London

Address: One Western Gateway, Royal Victoria Dock, London E16 1XL, United Kingdom



 

Program Overview

8:00 AM

15-19 April 2020

    2020 Scientific Programme will include:



    Educational sessions:



    Basic science highlights

    Basic science seminar: Liver immunology and immunotherapy, Breakfast morning rounds, Critical reflections on landmark papers, Grand rounds, Meet the experts

    Postgraduate course: End-stage liver disease, Pros and cons sessions, Public health sessions, Research think tanks, kills in hepatology, State-of-the-art lectures, Solve the case, Symposia

    Targeted sessions: Nurses and Allied Health Professionals Forum ,Hot topics in liver transplant ,Young investigators


    * Will happen in the brand new Hepatology Arena in Hall C

     



    Abstracts presented in different formats:



    Oral presentations: General sessions ,Parallel sessions 

    Poster presentations: ePoster screens ,Oral ePoster sessions ,Paper posters ,Poster tours ,Best poster session



8:00 AM - 5:30 PM

ExCeL Exhibition Centre, London, UK

15 April

8:30 AM

Wednesday, 15 April 2020



    Main Plenary     


    08:00 - 11:00- Research Think Tank – NAFLD - Metabolism, alcohol and toxicity

    11:30 - 13:30 -PGC - End stage liver disease: Diagnosis of cirrhosis & portal hypertension: non-invasive or invasive tests?

    14:00 - 15:30- PGC - End stage liver disease: Bleeding and thrombosis - Cirrhosis and complications



    Hall C3


    08:00 - 11:00 -Research Think Tank - Viral Hepatitis - Prevention: Vaccine and prisons - Viral hepatitis

    11:30 - 13:30 -Basic Science Seminar - Liver immunology and immunotherapy: Liver immunology - General hepatology

    11:30 - 13:30 - Basic Science Seminar - Liver immunology & immunotherapy: Liver immunology - General hepatology -Basic & translational science

    14:00 - 15:30 -Basic Science Seminar - Liver immunology and immunotherapy: From discovery to therapy - General hepatology - Basic & translational science  

    16:00 - 17:30 -Basic Science Seminar - Liver immunology & immunotherapy: Liver inflammation and immune-oncology - General hepatology - Basic & translational science  

    18:00 - 19:30 -Industry Symposium - Viral hepatitis



    Hall C1


    08:00 - 11:00 - Research Think Tank - Liver tumours - Liver tumours



    Hall C2


    08:00 - 11:00 -Research Think Tank - Hepatitis B cure - Viral hepatitis



    Strauss 1-2


    08:00 - 11:00 -Research Think Tank - Chronic liver failure: Newer concepts in the management of patients with decompensated cirrhosis - Cirrhosis & complications

    18:00 - 19:30 -Industry Symposium - Metabolism, alcohol & toxicity



    Strauss 3


    08:00 - 11:00 - Research Think Tank - Autoimmune and cholestatic liver diseases - Cholestasis and autoimmune (This session is co-organised with iPSCsg, AIHG & the Global PBC Study Group)

    18:00 - 19:30 -Industry Symposium - General hepatology



    Lehar 2


    08:00 - 11:00 - Research Think Tank - Addressing drug user health to achieve HCV elimination - Viral hepatitis  



    Lehar 3


    08:00 - 11:00 - Research Think Tank - Factors aggravating portal hypertension - General hepatology



    Lehar 4


    8:00 - 11:00 - Research Think Tank - Alcoholic liver disease: Screening for early ALD. Advantages & methods - Metabolism, alcohol & toxicity - Public health (This session is co-organised with ESBRA and SALVE)



    Hepatology Arena


    08:00 - 09:30 - Skills in hepatology: Liver tumour board - General hepatology - Imaging & interventional 

    10:00 - 11:00 -Skills in hepatology: Liver vascular disease board - General hepatology



    SLC 1


    18:00 - 19:30 -Skills learning centre: US simulators: Vascular liver disease and focal liver lesion - General hepatology - Imaging and interventional



8:30 AM - 7:30 PM

ExCeL Exhibition Centre, London, UK

16 April

7:30 AM

Thursday, 16 April 2020



    Main Plenary


    08:30 - 10:00 - PGC - End stage liver disease: Managing bacterial infections and impaired renal function

    10:30 - 12:00 - PGC - End stage liver disease: Hepatic encephalopathy and ACLF in end-stage liver disease

    12:00 - 12:30 - Translational state of the art lecture: Cell therapy in advanced liver disease

    13:30 - 15:30 - General session I and opening ceremony

    16:00 - 18:00 - Parallel session: Hepatitis B/D/E - Clinical aspects



    Hall C3


    08:30 - 10:00 - Basic Science Seminar - Liver immunology and immunotherapy: Exploiting adaptive and innate immune mechanisms

    10:30 - 12:00 - Basic Science Seminar - Liver immunology and immunotherapy: Disease applications: Viral hepatitis and cancer, cholestasis and fatty liver disease

    16:00 - 18:00 - Parallel session: Portal Hypertension - Refining risk stratification and therapy



    Hall C1


    07:30 - 08:30 - Industry Symposium

    12:00 - 13:30 - EASL Public Health Session: Influencing food and alcohol policy to reduce liver disease

    16:00 - 18:00 - Parallel session: NAFLD Pathophysiology - Target identification



    Hall C2


    12:00 - 13:30 - Data management in registries

    16:00 - 18:00 - Parallel session: Autoimmune and cholestasis I



    Strauss 1-2


    07:30 - 08:30 - Industry symposium

    16:00 - 18:00 - Parallel session: NAFLD - Clinical burden natural history



    Strauss 3


    07:30 - 08:30 - Industry Symposium

    09:00 - 11:20 - ELPA Symposium 2020 NAFLD and NASH from patient perspective: What are the patient problems?

    12:00 - 13:30 - EASL-ESCMID symposium: New diagnostic markers in viral hepatitis

    16:00 - 18:00 - Parallel session: Cascade of care towards elimination of viral hepatitis

    18:30 - 20:00 - Industry Symposium



    Lehar 1


    16:00 - 18:00 - Parallel session: Liver disease immunology



    Lehar 2


    12:00 - 13:30 - EASL Fellowship presentations

    16:00 - 18:00 - Parallel session: Mechanism of regeneration response to injury



7:30 AM - 8:00 PM

ExCeL Exhibition Centre, London, UK

17 April

7:30 AM

Friday, 17 April 2020



    Main Plenary


    08:30 - 10:30 - General session II and award ceremony I

    11:30 - 12:30 - Grand rounds: When to evaluate patients with NASH for HCC

    14:00 - 15:30 - Symposium: Albumin therapy in advanced liver disease - From plasma expander to pleiotropic agent

    16:00 - 18:00 - Parallel session: NAFLD - Clinical Therapy

    18:30 - 20:00 - Industry Symposium



    Hall C3


    11:30 - 12:30 - Grand rounds: Managing alcohol addiction and alcohol-related complications in patients with cirrhosis

    14:00 - 15:30 - EASL-APASL Symposium: Recognising and managing the lean NAFLD patient

    16:00 - 18:00 - Parallel session: Cirrhosis - Clinical aspects



     Hall C1


    11:30 - 17:30 - Hot topics in liver transplantation



    Hall C2


    11:30 - 12:30 - Grand rounds: Severe HCV extrahepatic manifestation

    16:00 - 18:00 - Parallel session: Hepatitis B - drug development



    Strauss 1-2


    11:30 - 12:30 - Grand rounds: Management of puritus

    14:00 - 15:30 - Fusion hepatology around the world: HCC - Special consideration in HBV infection

    16:00 - 18:00 - Parallel session: Liver cancer - From Prognosis to locoregional treatments



    Strauss 3


    07:30 - 08:20 - Breakfast morning rounds: Hepatitis Delta: how to manage? Are new therapies on the horizon?

    12:30 - 14:00 - EASL General Assembly

    16:00 - 18:00 - Parallel session: Autoimmune and cholestasis II

    18:30 - 20:00 - Industry Symposium



    Lehar 1


    14:00 - 15:30 - EASL-ESMO symposium: Multidisciplinary approach of Cholangiocarcinoma. From Diagnosis to treatment according to patient profile



    Lehar 2


    07:30 - 08:20 - Breakfast morning rounds: HCC therapy: When to use locoregional or systemic therapy and when to switch?

    10:00 - 11:30 - Nurses and Allied Health Professionals Forum: Case study session: Acute alcoholic hepatitis

    11:30 - 12:30 - EASL-WHO symposium: Promoting access to DAAs for children and adolescents?



    Lehar 3


    07:30 - 08:20 - Breakfast morning rounds: Differential diagnosis of hyperferritinemia in patients with liver disease

    11:30 - 12:30 - Basic science highlights: Single cell sequencing approaches in experimental hepatology



    Lehar 4


    07:30 - 08:20 - Breakfast morning rounds: Immune mediated hepatitis related to the new oncological therapies

    11:30 - 12:30 - Young investigators seminar: Critical thinking in science

    14:00 - 15:30 - EASL-ECDC Session:Using real world data to inform Hepatitis B and C elimination strategies



     

7:30 AM - 8:00 PM

ExCeL Exhibition Centre, London, UK

18 April

8:00 AM

Saturday, 18 April 2020



    Main Plenary


    08:00 - 09:45 - Parallel session: Hepatitis C - Treatment and resistance

    10:00 - 12:00 - General session III and award ceremony II

    12:00 - 12:30 - Karl Wilhelm von Kupffer basic state-of-the-art: The power of ONE: Immunology in the age of single cell genomics

    14:00 - 15:30 - Symposium: Patient prioritization for HCC treatment

    16:00 - 18:00 - Late Breaker



    Hall C3


    08:00 - 09:45 - Parallel session: Cirrrhosis - Experimental aspects

    12:30 - 14:00 - Industry Symposium

    14:00 - 15:30 - Symposium: Multidisciplinary approaches to the management of NAFLD



    Hall C1


    08:00 - 09:45 - Parallel session: NAFLD - Preclinical pipeline

    12:30 - 14:00 - Industry Symposium



    Hall C2


    08:00 - 09:45 - Parallel session: Liver cancer –  Systemic treatment  and immunotherapy

    14:00 - 15:30 - EASL-ALEH Symposium: DILI



    Strauss 1-2


    08:00 - 09:45 - Parallel session: Non-invasive assessment of liver disease

    14:00 - 16:00 - EASL-WHO symposium: Best practices and lessons learned from global viral hepatitis scale-up



    Strauss 3


    08:00 - 09:45 - Parallel session: Clinical developments in rare liver disease

    14:00 - 15:40 - YI Fusion: Research opportunities for young investigators in biliary diseases



    Lehar 1


    08:00 - 09:45 - Parallel session: Translational virology



    Lehar 2


    08:00 - 09:45 - Parallel session: Gut-Liver Axis

    14:00 - 15:30 - The best of JHep: 2015-2020



    Lehar 3


    08:00 - 09:45 - Parallel session: Liver transplantation I

    14:00 - 15:30 - Symposium: Bioartificial livers, cell therapies and tissue engineering – The future of regenerative hepatology?



    Lehar 4


    08:00 - 09:45 - Parallel session: Alcohol related liver disease

    14:00 - 15:30 -­ Young investigators seminar: Hepatology in 2030



    Poster Saturday 13 Apr


    09:00 - 17:00 - Poster: Liver tumours: Clinical aspects except therapy

    09:00 - 17:00 - Poster: Non-invasive assessment of liver disease except NAFLD

    09:00 - 17:00 - Poster: Cirrhosis and its complications: Clinical

    09:00 - 17:00 - Poster: Viral Hepatitis A, B, C, D, E: Virology

    09:00 - 17:00 - Poster: Immunology except viral hepatitis

    09:00 - 17:00 - Poster: Viral hepatitis A/E: Clinical aspects

    09:00 - 17:00 - Poster: Liver transplantation and hepatobiliary surgery: Experimental

    09:00 - 17:00 - Poster: Molecular and cellular biology

    09:00 - 17:00 - Poster: NAFLD: Diagnostics and non-invasive assessment

    09:00 - 17:00 - Poster: NAFLD: Therapy



8:00 AM - 6:00 PM

ExCeL Exhibition Centre, London, UK

19 April

7:30 AM

Sunday, 19 April 2020



    Strauss 1-2


    08:30 - 10:15 - Parallel session: NAFLD - Staging and prognosis

    11:30 - 13:00 - ILC 2020 wrap up session



    Strauss 3


    08:30 - 10:15 - Parallel session: Liver transplantation II

    10:30 - 11:30 - Symposium: Therapy of hepatitis C after DAA failure



    Lehar 1


    07:30 - 08:20 - Breakfast morning rounds: Extrahepatic manifestation of HCV: response to DAA and when to use immune suppression?



    Lehar 2


    07:30 - 08:20 - Breakfast morning rounds: Hepatitis B: when to start and when to stop Nuc therapy in HBeAg negative patients?

    10:30 - 11:30 ­ -Symposium: Preclinical models of NASH: in vitro, in vivo



    Lehar 3


    07:30 - 08:20 - Breakfast morning rounds: Cirrhosis and Portal hypertension: When TIPS, when and how Betablocker and how to monitor?

    10:30 - 11:30 - Symposium: What do you need to know about Hepatitis E



    Lehar 4


    07:30 - 08:20 - Breakfast morning rounds: PSC: how is the surveillance? when do we need interventions (ERC), when and how to use UDC? When to consider liver transplantation?

    08:30 - 10:00 - Liver disease and the community: Part 1: EASL Position papers - Alcohol and food

    10:30 - 11:30 - Liver disease and the community: Part 2: Hepatitis elimination



    Hepatology Arena


    08:30 - 09:30 - Solve the Case: HCC

    10:30 - 11:30 - Pro & Cons Session: PBC patients with inadequate response to UDCA: obeticholic acid ?



    Stolz 1


    08:30 - 09:20 - Meet the Experts: Portosinusoidal vascular disease: what is there behind this new name?

    09:30 - 10:20 - Meet the Experts: Management of non response to therapy in PBC patients

    10:30 - 11:20 - Meet the Experts: Acute liver failure



    Stolz 2


    08:30 - 09:20 - Meet the Experts: Haemochromatosis

    09:30 - 10:20 - Meet the Experts: Management of gastric varices

    10:30 - 11:20 - Meet the Experts: Pharmacotherapy in NAFLD - which endpoints to use in everyday practice?



7:30 AM - 11:30 PM

ExCeL Exhibition Centre, London, UK

×

YOU ARE INVITED!!

Book today & get 3% savings on Check out

Copy Invite Code
OR
Enter Promo Code: CHECK3 at Check Out

Special Offer Expiring Soon!!

×

Invite code copied for checkout.

Group Booking

Disclaimer: The website provides independent information to the visitors about event, venue, dates etc and suggest/book the best hotels and accommodation near the venue to attendees and are not directly associated with any Society. For Official Website, Click Here